p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells

P53 is a critical tumor suppressor that protects the integrity of genome and prevents cells from malignant transformation, including metastases. One of the driving forces behind the onset of metastases is the epithelial to mesenchymal transition (EMT) program. Zeb1 is one of the key transcription fa...

Full description

Bibliographic Details
Main Authors: Sergey E. Parfenyev, Sergey V. Shabelnikov, Elena N. Tolkunova, Nickolai A. Barlev, Alexey G. Mittenberg
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/12/9806
_version_ 1797594377639428096
author Sergey E. Parfenyev
Sergey V. Shabelnikov
Elena N. Tolkunova
Nickolai A. Barlev
Alexey G. Mittenberg
author_facet Sergey E. Parfenyev
Sergey V. Shabelnikov
Elena N. Tolkunova
Nickolai A. Barlev
Alexey G. Mittenberg
author_sort Sergey E. Parfenyev
collection DOAJ
description P53 is a critical tumor suppressor that protects the integrity of genome and prevents cells from malignant transformation, including metastases. One of the driving forces behind the onset of metastases is the epithelial to mesenchymal transition (EMT) program. Zeb1 is one of the key transcription factors that govern EMT (TF-EMT). Therefore, the interaction and mutual influence of p53 and Zeb1 plays a critical role in carcinogenesis. Another important feature of tumors is their heterogeneity mediated by the presence of so-called cancer stem cells (CSCs). To this end, we have developed a novel fluorescent reporter-based approach to enrich the population of CSCs in MCF7 cells with inducible expression of Zeb1. Using these engineered cell lines, we studied the effect of p53 on Zeb1 interactomes isolated from both CSCs and regular cancer cells. By employing co-immunoprecipitations followed by mass spectrometry, we found that the composition of Zeb1 interactome was affected not only by the p53 status but also by the level of Oct4/Sox2 expression, indicating that stemness likely affects the specificity of Zeb1 interactions. This study, together with other proteomic studies of TF-EMT interactomes, provides a framework for future molecular analyses of biological functions of Zeb1 at all stages of oncogenesis.
first_indexed 2024-03-11T02:22:51Z
format Article
id doaj.art-cb47e00f21cd484e8a837d6d7331b5a9
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T02:22:51Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-cb47e00f21cd484e8a837d6d7331b5a92023-11-18T10:44:22ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-06-012412980610.3390/ijms24129806p53 Affects Zeb1 Interactome of Breast Cancer Stem CellsSergey E. Parfenyev0Sergey V. Shabelnikov1Elena N. Tolkunova2Nickolai A. Barlev3Alexey G. Mittenberg4Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, RussiaInstitute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, RussiaInstitute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, RussiaInstitute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, RussiaInstitute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, RussiaP53 is a critical tumor suppressor that protects the integrity of genome and prevents cells from malignant transformation, including metastases. One of the driving forces behind the onset of metastases is the epithelial to mesenchymal transition (EMT) program. Zeb1 is one of the key transcription factors that govern EMT (TF-EMT). Therefore, the interaction and mutual influence of p53 and Zeb1 plays a critical role in carcinogenesis. Another important feature of tumors is their heterogeneity mediated by the presence of so-called cancer stem cells (CSCs). To this end, we have developed a novel fluorescent reporter-based approach to enrich the population of CSCs in MCF7 cells with inducible expression of Zeb1. Using these engineered cell lines, we studied the effect of p53 on Zeb1 interactomes isolated from both CSCs and regular cancer cells. By employing co-immunoprecipitations followed by mass spectrometry, we found that the composition of Zeb1 interactome was affected not only by the p53 status but also by the level of Oct4/Sox2 expression, indicating that stemness likely affects the specificity of Zeb1 interactions. This study, together with other proteomic studies of TF-EMT interactomes, provides a framework for future molecular analyses of biological functions of Zeb1 at all stages of oncogenesis.https://www.mdpi.com/1422-0067/24/12/9806breast cancercancer stem cellsepithelial-to-mesenchymal transition (EMT)metastasisp53Zeb1
spellingShingle Sergey E. Parfenyev
Sergey V. Shabelnikov
Elena N. Tolkunova
Nickolai A. Barlev
Alexey G. Mittenberg
p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells
International Journal of Molecular Sciences
breast cancer
cancer stem cells
epithelial-to-mesenchymal transition (EMT)
metastasis
p53
Zeb1
title p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells
title_full p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells
title_fullStr p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells
title_full_unstemmed p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells
title_short p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells
title_sort p53 affects zeb1 interactome of breast cancer stem cells
topic breast cancer
cancer stem cells
epithelial-to-mesenchymal transition (EMT)
metastasis
p53
Zeb1
url https://www.mdpi.com/1422-0067/24/12/9806
work_keys_str_mv AT sergeyeparfenyev p53affectszeb1interactomeofbreastcancerstemcells
AT sergeyvshabelnikov p53affectszeb1interactomeofbreastcancerstemcells
AT elenantolkunova p53affectszeb1interactomeofbreastcancerstemcells
AT nickolaiabarlev p53affectszeb1interactomeofbreastcancerstemcells
AT alexeygmittenberg p53affectszeb1interactomeofbreastcancerstemcells